Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

Clinical trial NCT07161843 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07161843
Sponsor: Ebima Clifford Okundaye
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Renal Failure (ARF)Acute Tubular Necrosis

Start date: 2026-06-30
Primary completion: 2026-12-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.